Ukurasa 1 kutoka 167 matokeo
In a preliminary study, plasma testosterone values were obtained by the RIA method from 2 groups of cluster headache males at separate laboratories. Within each group the mean testosterone levels were compared between normal control and cluster patients in active and remission periods. Significantly
Serum testosterone level was determined by radioimmunoassay in 57 men, including 23 cases of Horton's neuralgia during the period of recurrent headaches but not during an attack of headache, in 10 cases of trigeminal neuralgia, 10 cases of radicular pain and in 14 blood donors. Only in the blood
The study was carried out on 15 men suffering from the episodic form (12 patients) and the chronic one (3 patients) of cluster headache. Before treatment the patients did not receive any drugs, and after determining the index of attacks the treatment was commenced. For 7-10 days patients were given
Short-lasting chronic testosterone administration did not change the course of cluster headache in seven chronic sufferers, whereas it enhanced sexual excitement in comparison with male control subjects who received the same treatment. We postulate that the sexual excitement induced in cluster
The studied material comprised 15 men with 12 of them having the episodic from of Horton's headaches and 3 with chronic form. In the episodic form the age of the patients was from 32 to 48 years, mean age 38. The history of the disease was from 6 to 12 years, the duration of a spell of headaches was
The circadian changes in testosterone (T) and cortisol secretion and morning luteinizing hormone (LH) levels were evaluated in nine episodic cluster headache (CH) patients in active phase and in seven healthy volunteers, with collection of blood samples every 2 h for 24 h. CH showed a significant
Serum levels of various hormones have been estimated in cluster headache and non-cluster headache controls. Cluster headache patients were studied prior to, during, and after attack. During the cluster phase, plasma testosterone levels were low, whereas levels were within the reference limits.
OBJECTIVE
To describe the clinical characteristics and laboratory findings of cluster headache patients whose headaches responded to testosterone replacement therapy.
BACKGROUND
Current evidence points to hypothalamic dysfunction, with increased metabolic hyperactivity in the region of the
The purpose of this prospective pilot study was to determine the therapeutic effect of continuous testosterone, delivered as a subcutaneous implant, on the severity of migraine headaches in pre- and post-menopausal patients. Twenty-seven women with a history of documented migraine headache were
BACKGROUND
Erectile dysfunction (ED), defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance, is a common condition. The psychological, hormonal, neurogenic and arterial pathologies, medications, chronic diseases have been reported in the etiology
The effectiveness of cyproterone acetate, a synthetic steroid with antiandrogenic action, was tested in 40 (young, adult) males, suffering from episodic (29) and chronic (11) cluster headache. Previously a minority (15) cases had been unsuccessfully treated with lithium, the conventional therapy of